Son avis en 2006 était plus on retarde le traitement mieux c'est.
If treatment is inevitable, my choice would be the treatment that is least harmful. At the moment this is rituximab. It only works in about half the patients, and it does lower the levels of normal B cells, but this is transient and they quickly return. Rituximab plus a growth factor like G-CSF or GM-CSF may well be more effective. So if it works for you and gives you a year off treatment then go for it, and don’t be afraid to repeat it. True rituximab resistance is very rare. In some patients increasing the dose will turn a non-responder into a responder.
From Blog
http://mutated-unmuated.blogspot.com/2006_01_01_archive.html
Aucun commentaire:
Enregistrer un commentaire